NYSE:HUM - Humana Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$293.20 -0.10 (-0.03 %)
(As of 01/17/2019 11:22 AM ET)
Previous Close$293.30
Today's Range$290.16 - $293.89
52-Week Range$260.00 - $355.88
Volume9,375 shs
Average Volume1.02 million shs
Market Capitalization$39.59 billion
P/E Ratio25.04
Dividend Yield0.35%
Beta1.09
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts. This segment also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. The Group and Specialty segment provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health and voluntary insurance benefits; financial protection products; and administrative services only products to individuals and employer groups. It also offers military services, such as TRICARE South Region contract. The Healthcare Services segment provides pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. The Individual Commercial segment offers individual commercial fully-insured medical health insurance benefits under the HumanaOne brand. The company also provides closed-block long-term care insurance policies. As of December 31, 2017, it had approximately 14 million members in medical benefit plans, as well as approximately 7 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Receive HUM News and Ratings via Email

Sign-up to receive the latest news and ratings for HUM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
CUSIP44485910
Phone502-580-1000

Debt

Current Ratio1.68
Quick Ratio1.68

Price-To-Earnings

Sales & Book Value

Annual Sales$53.77 billion
Price / Sales0.75
Cash Flow$15.5792 per share
Price / Cash Flow18.82
Book Value$68.89 per share
Price / Book4.26

Profitability

Net Income$2.45 billion
Net Margins2.70%
Return on Assets6.36%

Miscellaneous

Employees45,900
Market Cap$39.59 billion
OptionableOptionable

Humana (NYSE:HUM) Frequently Asked Questions

What is Humana's stock symbol?

Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."

How often does Humana pay dividends? What is the dividend yield for Humana?

Humana declared a quarterly dividend on Friday, November 2nd. Stockholders of record on Monday, December 31st will be paid a dividend of $0.50 per share on Friday, January 25th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.68%. The ex-dividend date of this dividend is Friday, December 28th. View Humana's Dividend History.

How will Humana's stock buyback program work?

Humana announced that its board has authorized a stock repurchase program on Friday, December 15th 2017, which allows the company to repurchase $3,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to buy shares of its stock through open market purchases. Stock repurchase programs are usually a sign that the company's board of directors believes its shares are undervalued.

How were Humana's earnings last quarter?

Humana Inc (NYSE:HUM) announced its quarterly earnings data on Wednesday, November, 7th. The insurance provider reported $4.58 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $4.29 by $0.29. The insurance provider had revenue of $14.21 billion for the quarter, compared to analysts' expectations of $13.97 billion. Humana had a return on equity of 19.10% and a net margin of 2.70%. During the same period last year, the firm posted $3.39 EPS. View Humana's Earnings History.

When is Humana's next earnings date?

Humana is scheduled to release their next quarterly earnings announcement on Wednesday, February 6th 2019. View Earnings Estimates for Humana.

How can I listen to Humana's earnings call?

Humana will be holding an earnings conference call on Wednesday, February 6th at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 8886257430.

What guidance has Humana issued on next quarter's earnings?

Humana issued an update on its FY18 earnings guidance on Wednesday, November, 28th. The company provided earnings per share (EPS) guidance of $14.40 for the period, compared to the Thomson Reuters consensus EPS estimate of $14.43.

What price target have analysts set for HUM?

18 brokers have issued 1 year target prices for Humana's shares. Their predictions range from $270.00 to $418.00. On average, they anticipate Humana's stock price to reach $349.89 in the next twelve months. This suggests a possible upside of 19.3% from the stock's current price. View Analyst Price Targets for Humana.

What is the consensus analysts' recommendation for Humana?

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Humana in the last year. There are currently 4 hold ratings and 14 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Humana.

What are Wall Street analysts saying about Humana stock?

Here are some recent quotes from research analysts about Humana stock:
  • 1. Cantor Fitzgerald analysts commented, ". We reiterate our Neutral rating on HUM shares and maintain our 12-month price target of $325. After the market close on the company reaffirmed its 2018 EPS guidance. The company also provided updated 2019 membership metrics. Given the update, we are increasing our 2019 revenue and EPS estimates. The company had previously indicated that it expected 2019 adjusted EPS to grow above its stated long-term goal of 11-15%. With its filing on Wednesday, the company did not comment on 2019 EPS guidance, but will provide detailed 2019 financial guidance when it reports 4Q18 and year-end 2018 results on Wednesday, February 6, 2019." (1/2/2019)
  • 2. According to Zacks Investment Research, "Humana’s shares have outperformed its industry’s growth in a year’s time. The insurer is well-poised for growth on the back of its strong Medicare business. Its top line has been witnessing an uptrend for the past several years. Sufficient generation of cash flow has helped the company take up many capital deployment initiatives aimed at enhancing its shareholder value. Acquisitions and dispositions made by the company have also led to business growth over the last few quarters. However, its rising level of expenses since 2010 persistently weighs on the bottom line. The company expects to witness rise in benefit expenses which will lead to an overall increase in operating expenses going forward." (12/31/2018)

Has Humana been receiving favorable news coverage?

News coverage about HUM stock has been trending positive on Thursday, InfoTrie reports. InfoTrie ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Humana earned a media sentiment score of 2.6 on InfoTrie's scale. They also assigned news stories about the insurance provider a news buzz of 8.0 out of 10, indicating that recent media coverage is very likely to have an impact on the company's share price in the next several days.

Are investors shorting Humana?

Humana saw a increase in short interest in the month of November. As of November 30th, there was short interest totalling 3,549,873 shares, an increase of 63.6% from the November 15th total of 2,170,421 shares. Based on an average daily volume of 1,124,142 shares, the short-interest ratio is currently 3.2 days. Approximately 2.6% of the shares of the company are short sold. View Humana's Current Options Chain.

Who are some of Humana's key competitors?

Who are Humana's key executives?

Humana's management team includes the folowing people:
  • Mr. Bruce Dale Broussard, Pres, CEO & Director (Age 57)
  • Mr. Brian Andrew Kane, Sr. VP & CFO (Age 46)
  • Mr. Christopher Mark Todoroff, Chief Legal Officer (Age 56)
  • Mr. Timothy S. Huval, Chief HR Officer (Age 53)
  • Ms. Jody L. Bilney, Chief Consumer Officer (Age 58)

Who are Humana's major shareholders?

Humana's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include DNB Asset Management AS (0.06%), Scout Investments Inc. (0.03%), State of Alaska Department of Revenue (0.03%), Gulf International Bank UK Ltd (0.02%), CHURCHILL MANAGEMENT Corp (0.02%) and Ferguson Wellman Capital Management Inc. (0.01%). Company insiders that own Humana stock include Brian P Leclaire, Bruce D Broussard, Christopher H Hunter, Cynthia H Zipperle, David A Jr/Ky Jones, Elizabeth D Bierbower, Heidi S Margulis, James E Murray, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming. View Institutional Ownership Trends for Humana.

Which major investors are selling Humana stock?

HUM stock was sold by a variety of institutional investors in the last quarter, including Gulf International Bank UK Ltd, Meeder Asset Management Inc., Boston Advisors LLC, State of Alaska Department of Revenue, Highland Capital Management LLC, First Midwest Bank Trust Division, First Hawaiian Bank and CHURCHILL MANAGEMENT Corp. Company insiders that have sold Humana company stock in the last year include Bruce D Broussard, Christopher H Hunter, Cynthia H Zipperle, Elizabeth D Bierbower, Heidi S Margulis, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge, Timothy Alan Wheatley and William Kevin Fleming. View Insider Buying and Selling for Humana.

Which major investors are buying Humana stock?

HUM stock was bought by a variety of institutional investors in the last quarter, including DNB Asset Management AS, MinichMacGregor Wealth Management LLC, Monument Capital Management, QUANTRES ASSET MANAGEMENT Ltd, Town & Country Bank & Trust CO dba First Bankers Trust CO, Steward Partners Investment Advisory LLC, Hudson Capital Management LLC and Cerebellum GP LLC. View Insider Buying and Selling for Humana.

How do I buy shares of Humana?

Shares of HUM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Humana's stock price today?

One share of HUM stock can currently be purchased for approximately $293.29.

How big of a company is Humana?

Humana has a market capitalization of $39.59 billion and generates $53.77 billion in revenue each year. The insurance provider earns $2.45 billion in net income (profit) each year or $11.71 on an earnings per share basis. Humana employs 45,900 workers across the globe.

What is Humana's official website?

The official website for Humana is http://www.humana.com.

How can I contact Humana?

Humana's mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The insurance provider can be reached via phone at 502-580-1000 or via email at [email protected]


MarketBeat Community Rating for Humana (NYSE HUM)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  703 (Vote Outperform)
Underperform Votes:  755 (Vote Underperform)
Total Votes:  1,458
MarketBeat's community ratings are surveys of what our community members think about Humana and other stocks. Vote "Outperform" if you believe HUM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HUM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel